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RankingHospital acquired complications (HACs) are serious problems affecting modern day healthcare institu-
tions. It is estimated that HACs result in an approximately 10% increase in total inpatient hospital costs
across US hospitals. With US hospital spending totaling nearly $900 billion per annum, the damages
caused by HACs are no small matter. Early detection and prevention of HACs could greatly reduce strains
on the US healthcare system and improve patient morbidity & mortality rates. Here, we describe a
machine-learning model for predicting the occurrence of HACs within five distinct categories using tem-
poral clinical data. Using our approach, we find that at least $10 billion of excessive hospital costs could
be saved in the US alone, with the institution of effective preventive measures. In addition, we also iden-
tify several keystone features that demonstrate high predictive power for HACs over different time peri-
ods following patient admission. The classifiers and features analyzed in this study show high promise of
being able to be used for accurate prediction of HACs in clinical settings, and furthermore provide novel
insights into the contribution of various clinical factors to the risk of developing HACs as a function of
healthcare system exposure.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Hospital acquired complications (HACs) are secondary compli-
cations that affect patients following initial hospital admission.
Most commonly, these problems are caused by healthcare-
associated infections and other issues resulting as side effects from
primary treatments such as surgery. Although well known to
occur, many HACs are not identified in a timely manner, and often
lead to further medical issues causing increased hospitalization
time, temporary and permanent morbidities, or even death. It
has been estimated that HACs alone cause nearly 99,000 deathsannually in the United States [1] and lead to an approximately
10% increase in total inpatient hospital costs [2]. Early identifica-
tion of HACs using electronic health records (EHRs) may lead to
prevention or proactive treatment, ultimately increasing patient
care quality and reducing unnecessary inpatient costs.
The development and deployment of large-scale EHR databases
has led to a surge in medical informatics over the past several years
[3–6]. In particular, phenotypes across the human ‘‘phenome” have
been shown to have significant associations with genotype and
with lab features [7–9]. Since the manifestation of a HAC is also
a patient phenotype, it follows that there may be a way to identify
and predict HACs using temporal information that unfolds during a
hospitalization. We have previously shown that certain patient
phenotypes, many of which are HACs, are associated with pro-
longed hospitalization [10].
The Multiparameter Intelligent Monitoring in Intensive Care
(MIMIC II) database contains extensive structured clinical informa-
tion on patients admitted to any of the Beth Israel Deaconess Med-
ical Center Intensive Care Units (ICUs) between 2001 and 2007,
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component [11]. MIMIC II also contains some narrative informa-
tion: nursing documentation, radiology reports, and Discharge
Summaries. Here, we propose to use MIMIC II to develop predictive
models to detect HACs early on in hospitalization, possibly in
advance of their occurrence. As a secondary objective, we hypoth-
esized that the relative contribution of predictor variables (e.g.
patient age, lab results, and medication orders) would change as
a function of the timespan used to generate the predictive model.
Analysis of this rich medical cohort can lead to new discoveries
for the prediction and possible early prevention of problematic
HACs.2. Methods
2.1. Data extraction and modeling
To identify HACs in the MIMIC II cohort, we used a candidate list
of International Classification of Diseases, 9th Edition, Clinical
Modification (ICD-9-CM) codes that were previously determined
to be associated with an increased risk of prolonged hospitalization
[10]. These and additional ICD-9-CM codes were manually
reviewed and all codes that were indicative of HACs were used
to identify patients having HACs. A total of 414 ICD-9-CM codes
were selected through this process. We further categorized each
identified ICD-9-CM code into five subcategories: (1) infectious
complications; (2) bleeding or clotting complications; (3) surgi-
cal/procedural complications; (4) medical complications; and (5)
all other complications (Table A1). In order to decrease the possi-
bility that a candidate code was representative of a pre-existing
condition, we compared our candidate list to the Elixhauser
AHRQ-Web ICD-9-CM list of comorbidities [12,13]. There were 2
overlaps (287.41: post-transfusion purpura & 276.61: transfusion
with circulatory overload), but neither of these codes was present
in the MIMIC II cohort. We also manually reviewed the Discharge
Summaries from 50 randomly selected admissions from each sub-
category to determine whether the complication was the result of a
prior healthcare event (e.g. a preceding outpatient procedure, or a
previous hospitalization).Fig. 1. Illustration of two level classifier model used in this study. The bottom level (IC
produce a probability of observing the ICD-9-CM code. The top level (HAC prediction) m
classification on whether or not a given patient falls under a HAC category.All adult MIMIC II hospitalizations having one or more of these
identified diagnosis codes assigned at discharge were considered
cases, and an equal number of hospital admissions were randomly
sampled from the remaining MIMIC II hospitalizations as controls,
excluding those of duration outside the 1st to 99th percentiles of
the cases. Patients with more than one hospitalization could be
assigned to case or control groups, based on the ICD-9-CM codes
obtained for a particular hospital stay.
Structured data was extracted from MIMIC II for both cases and
controls, beginning at the time of initial contact, which usually
occurs in the outpatient setting (e.g. the emergency room). Initial
and last contact of a patient was algorithmically defined based
on our prior definition [10]. Clinical information was extracted
for each admission based on time intervals of 1, 2, 3, 6, 12, 18,
24, 48, 72, and 96 h following initial contact; patients whose last
contact times were outside of the specified interval were censored
for that interval. Structured information was extracted by record-
ing the maximum, minimum, and median values for continuous
lab results, the mode for categorical lab results, any procedure
codes (ever/never), and any medication provider order entry
(POE) (ever/never) time-stamped during each interval. In order to
increase power, we developed a large library of custom medication
aggregations e.g. to combine a medication given by more than one
route but with the same predicted pharmacologic effect (Appendix
B). Patient demographics (age at admission, gender, and ethnicity)
were included as well.
To prevent excessive noise, over-fitting, and unreasonable
demands on the prediction model, initial feature selection was car-
ried out as follows: lab features missing in more than 50% and POE/
procedure features missing in more than 95% of our cohort were
removed prior to classifier construction. Following feature selec-
tion, multiple imputation was performed using the aregImpute
algorithm to impute missing values (R package Hmisc) [14].
2.2. Feature ranking
To assess the predictive power of individual features, we com-
puted the information gain ratio of each attribute relative to the
class feature [15]. Attributes with high information gain ratios with
respect to the classification attribute (presence of HAC) are likelyD-9-CM prediction) model is a Bayesian network that uses patient information to
odel uses confidences given by the first level Bayesian network to perform binary
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butes were ranked by their information gain ratios to identify the
relative predictive power of each attribute over each time interval.
Attributes which are consistently ranked as having the highest
information gain or undergo sudden changes in their rankings over
time would be of particular interest to clinicians, as closely observ-
ing these specific attributes may help lead to earlier detections of
HACs.ar
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0%2.3. Classification
To perform classification, we employed a two level model to
predict each HAC category. From the selected case/control cohort
for each HAC category, we generated multiple subcohorts for each
identified ICD-9-CM code linked to HACs by selecting all patients
with the given ICD-9-CM code as cases and randomly selecting
an equal number of the remainder as controls. Bayesian network
classifiers were then trained on the generated subcohorts using a
tree-augmented naïve Bayes (TAN) search algorithm [16,17]. Each
of the trained Bayesian networks would then be able to report the
posterior probability of each patient having a given ICD-9-CM
value using that patient’s feature set. We then trained a secondary
classifier using AdaBoosted decision stumps on top of these Baye-
sian network models using the generated posterior probabilities
reported by each Bayesian network classifier as features to predict
the occurrence of each HAC category. The AdaboostM1 algorithm
[18] was used with 100 training iterations with boosting per-
formed by reweighting rather than resampling. The Weka Machine
Learning Library [19] implementation of TAN Bayes and Ada-
boostM1 was used for this study. A graphical illustration of this
two level classifier can be seen in Fig. 1.
The structure of the two-layer classification model can be seen
as something similar to a neural network consisting of five output
nodes (the five HAC categories), a single hidden layer consisting of
414 hidden nodes (each of the identified ICD-9-CM codes), and
input nodes being the lab/procedural features. However, instead
of learning the entire network simultaneously, we first force each
of the hidden nodes to learn the posterior probability of the patient
having the given ICD-9-CM code. Then, we have the output nodes
learn the whether or not the patient has a HAC from the given cat-
egory using the predicted probabilities from each of the hidden
nodes. We found that while classifiers did not have much success
in predicting the general HAC category directly, they were able
to predict individual ICD-9-CM codes quite accurately so this
two-level model takes advantage of that effect to strengthen our
predictive power.Ta
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The MIMIC II cohort at time of analysis contained a total of
24,580 records for adult hospitalizations. While some patients
are admitted directly to the ICU, the majority spend some period
of time on an ordinary hospital floor prior to ICU transfer (median
time from hospital admission to ICU admission of 19.5 h,
interquartile range 12–41 h). Of the entire cohort, we identified
1468 admissions with infectious complications, 1912 admissions
with bleeding or clotting complications, 4507 admissions with sur-
gical complications, 484 admissions with medical complications,
and 2423 admissions with other complications (numbers fluctuate
slightly depending on time interval queried due to some patients
not having any lab/procedural/POE entries over smaller intervals
and being discharged over larger intervals). In total, there were
8183 unique admissions with one or more candidate codes within
our cohort (33% of all adult admissions). Approximately 50% of
these had a Discharge Summary available for review, which were
212 J.L. Warner et al. / Journal of Biomedical Informatics 59 (2016) 209–217randomly sampled as described above. Overall, only 10% of compli-
cations (95% confidence interval, 7–14%) were determined to be
pre-existing – although a significant number could not be deter-
mined by manual review of the Discharge Summary (see Table 1).
In the extracted data for patient information obtained during
the first hour after initial contact, we found 20 lab features, 45
medication features, and 23 procedural features that passed our
feature selection criteria. This number steadily increased to a total
of 48 lab features, 135 medication features, and 107 procedural
features for the extracted data obtained during the 96 h after initial
contact. Thus, we had a range of 91 events per feature at the 1-h
mark and 25 events per feature at the 96-h mark.
Full rankings of all extracted features based on information gain
ratio with respect to the presence of each HAC category can be
found in Appendix B. Tables 2–4 demonstrate selected ‘‘interest-
ing” features from the full rankings. Table 2 shows the top three
features for each category as measured by the highest mean rank
among all the time intervals. Tables 3 and 4 show the top two fea-
tures for each category as measured by the slope of their changeTable 2
Top three features with the highest mean rank over the time intervals for each category. Fe
intervals. Only the top ranking statistic for each lab value is included. NA: feature did not m
Attribute name Hour
1 2
Category 1 – Infectious complications
Red Blood Cell Distribution Width (RDW) median lab value 14 7
Parenteral infusion procedure NA 3
Vancomycin medication 37 12
Category 2 – Bleeding or clotting complications
Serum transfusion procedure 16 3
Partial Thromboplastin Time (PTT) maximum lab value 49 14
Hematocrit (HCT) minimum lab value 35 55
Category 3 – Surgical complications
Neostigmine medication NA NA
Glycopyrrolate medication NA NA
Ceftriaxone medication NA NA
Category 4 – Medical complications
Ethnicity 4 1
Red Blood Cell Distribution Width (RDW) maximum lab value 3 4
Atropine sulfate medication 18 15
Category 5 – Other complications
Chlorhexidine medication NA NA
Skin suture procedure 10 7
Infusion of vasopressor procedure NA 5
Table 3
Top two features with the largest increase over the time intervals as measured by the line
seven of the 10 time intervals and their max ranking was within the top 10 at some interva
initial selection criteria for that time interval so was not included in the classifier.
Attribute name Hour
1 2
Category 1 – Infectious complications
Single internal mammary-coronary artery bypass procedure NA 43
Aortocoronary bypass procedure NA 44
Category 2 – Bleeding or clotting complications
Corpuscular hemoglobin concentration maximum lab value 87 165
Platelet transfusion procedure NA 1
Category 3 – Surgical complications
Neosynephrine medication 99 100
Nitroglycerin medication 89 145
Category 4 – Medical complications
Nitroprusside medication 90 143
IV line flush 97 129
Category 5 – Other complications
Lansoprazole medication NA NA
Insertion of intercostal catheter procedure 42 61over the time intervals (negative and positive slopes, respectively).
Fig. 2 also summarizes this information.
Fig. 3 visualizes the change in AUC for the classifiers over the
increasing time intervals for each category. TPR, TNR, and AUC of
the classifiers can be found in Table A2 and full information can
be found in Appendix B.
4. Discussion
Our analysis of a large-scale critically ill clinical cohort revealed
several features demonstrating good predictive power for identify-
ing HACs. Depending on the nature of the feature, careful observa-
tion for significant changes (e.g. for lab values) or awareness that
an event has occurred (e.g. for procedures) may allow for earlier
detection of HACs during hospitalizations, and perhaps a reduction
in costs. Of course, due to the fact that ICD-9-CM diagnosis codes
are assigned at the end of a hospitalization, we cannot conclude
using our current approach the exact time after initial contact that
each HAC develops. In fact, our manual review of Dischargeatures were only included if they existed in the data for at least seven of the ten time
eet initial selection criteria for that time interval so was not included in the classifier.
3 6 12 18 24 48 72 96
17 2 3 1 3 3 10 38
6 38 11 10 25 6 5 9
1 3 1 2 1 1 2 108
20 5 27 17 16 14 11 4
41 2 5 22 10 2 8 7
34 12 10 4 7 1 4 3
42 2 1 1 1 1 4 6
38 1 2 2 2 4 7 9
NA 31 10 10 3 18 2 3
1 4 5 2 1 14 14 104
3 1 3 1 2 1 9 125
54 20 51 21 29 7 3 13
NA 1 2 2 1 1 1 1
1 3 15 60 50 NA NA NA
14 33 1 26 16 7 76 10
ar regression slope. Features were only included if they existed in the data for at least
l. Only the top ranking statistic for each lab value is included. NA: feature did not meet
Slope
3 6 12 18 24 48 72 96
44 72 10 13 10 11 6 3 0.457
45 73 13 17 9 19 12 11 0.379
135 25 49 131 109 5 18 18 1.130
19 150 35 9 9 17 10 6 0.457
121 25 12 16 16 8 13 8 0.820
99 12 5 8 5 9 11 16 0.754
122 14 9 8 13 23 12 5 0.868
128 43 55 33 32 71 5 29 0.809
NA 90 97 11 95 3 20 3 0.945
158 21 9 5 21 5 34 2 0.584
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healthcare-associated complications that were present at the time
of hospital admission. Unfortunately, it can be very challenging to
identify these cases through automated methods. MIMIC II does
not have admitting diagnosis as structured data, nor does it have
admission H&Ps or clinician progress notes. When the Discharge
Summary is available (50% of the time), the narrative is highly
variable and requires extensive temporal reasoning, which has
been described as a ‘‘very challenging area” for clinical natural lan-
guage processing [20]. Thus, at this point in the pilot work, we can-
not determine with absolute confidence how much earlier our
developed classifier may detect HACs when compared to the time
of discovery by hospital personnel. Future work will evaluate
whether the recent open-source temporal solution described by
Lin et al. can assist with the determination of the temporality of
the complications, including whether they were present at the
time of admission – although the substantial degree of unknown
determination even after manual review indicates that this task
will remain challenging [21]. Interestingly, medical complications
(e.g. constipation from narcotics, renal failure from diuretics) were
especially likely to remain undetermined after manual review; one
possibility is that these are so widespread that they are considered
part of the routine consequences of medical care and are thus not
extensively documented.
Furthermore, it is possible that features could reflect the treat-
ment of HACs as opposed to being their causation. It is also possi-
ble that what we are classifying as a HAC could have been a pre-
existing condition (including the reason for hospitalization in the
first place), but we tried to ameliorate this possibility by ensuring
that none of the HAC candidate codes overlapped with the Elix-
hauser comorbidity codes. Although some clinical systems have a
‘‘present on admission” (POA) flag to identify pre-existing condi-
tions, MIMIC II does not have this information. Even with these
limitations, several interesting patterns emerge in this analysis,
as discussed in the following sections:
4.1. Feature rankings
Examination of how the relative contribution of individual lab,
procedural, and medication features to the model changes as a
function of time revealed several interesting patterns. The vast
majority of features identified in our data fell under one of four
possible categories: features that were consistently highly rankedTable 4
Top two features with the largest decrease over the time intervals as measured by the line
seven of the 10 time intervals and their max ranking was within the top 10 at some interva
selection criteria for that time interval so was not included in the classifier.
Attribute name Hour
1 2
Category 1 – Infectious complications
Red Blood Cell Count (RBC) maximum lab value 39 14
Hematocrit (HCT) maximum lab value 29 11
Category 2 – Bleeding or clotting complications
Basophils maximum lab value NA 4
Hemoglobin (HGB) maximum lab value 39 53
Category 3 – Surgical Complications
Basophils median lab value NA 7
Monocytes minimum lab value NA 97
Category 4 – Medical complications
Hemoglobin (HGB) maximum lab value 9 18
Insertion of endotracheal tube procedure 115 32
Category 5 – Other complications
Red Blood Cell Distribution Width (RDW) maximum lab value 6 1
Hemoglobin (HGB) maximum lab value 22 13across all time intervals (selected features displayed in Table 2),
features that started at low ranks but became highly ranked as
the time intervals increased (Table 3), features that started at high
ranks but steadily decreased as time intervals increased (Table 4),
or features that were generally poorly ranked across all time
intervals.
Early in a hospitalization, features that measure patient physi-
ology, such as hematologic and chemistry parameters, clearly drive
the model. As the time horizons lengthen, features that represent
procedural and medical interventions begin to dominate the
model. While causality cannot be determined from this analysis
(e.g. procedures such as platelet transfusion may cause complica-
tions, or could be used to treat complications), there is certainly
the suggestion that the interventionist approach ubiquitous in
the United States healthcare system is a strong driver of HAC phe-
notypes. These findings indicate that the patient features clinicians
should pay close attention to for early HAC detection evolve as a
function of a patient’s time from admission.
Looking at the top increasing and decreasing features for the
various categories (Fig. 2), a common trend is that the initial
incline and decline in feature rankings are observed at the same
hour. For example, in infectious complications single internal
mammary-coronary artery bypass procedure and aortocoronary
bypass procedure both start to rise in rank at hour 12 while red
blood cell count (RBC) and hematocrit (HCT) also start to decrease
in rank at hour 12. Looking across all categories, this suggests that
hours 6–18 are crucial for observing initial incline and decline of
features to predict which category of HAC will occur, which agrees
with previous literature [22–30]. Another interesting commonality
is that bleeding or clotting complications (Fig. 2b), medical compli-
cations (Fig. 2d), and other complications (Fig. 2e) share the feature
that measures hemoglobin (HGB) maximum lab value as one of the
top 2 largest decreasing features. This suggests that hemoglobin
(HGB) maximum lab value could be a feature to help predict HAC
within the first 18 h [31–35]. This data supports the notion that
the first 24 h of a critical illness admission are crucial and that
excessive handoffs during this period are likely to be problematic
[36].
One of the consistently highly ranked features found in this
study is RDW, which agrees with previous literature that has found
RDW to be a good independent predictor of morbidity [37], mortal-
ity [38], and hospital readmission [39]. In addition, while lab fea-
tures tend to dominate the model during early intervals andar regression slope. Features were only included if they existed in the data for at least
l. Only the top statistic for each lab value is included. NA: feature did not meet initial
Slope
3 6 12 18 24 48 72 96
12 9 20 24 62 168 148 189 +2.010
7 14 26 21 45 139 147 170 +1.862
5 34 206 227 176 256 286 370 +3.390
10 67 58 118 133 150 180 254 +2.152
3 43 196 243 231 309 366 364 +3.731
1 114 210 212 245 302 288 309 +2.482
22 16 8 35 21 54 149 245 +2.235
4 151 252 212 78 178 274 295 +2.187
5 5 11 21 5 115 230 239 +2.815
9 13 38 24 105 140 246 249 +2.811
Fig. 2. Top two features with the largest decrease and top two features with the largest increase over the time intervals as measured by the linear regression slope for each
category. Features were only included if they existed in the data for at least seven of the 10 time intervals and their max ranking was within the top 10 at some interval. Only
the top statistic for each lab value is included.
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Fig. 3. AUC of HAC predicting classifiers for each category over the data collection periods.
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good number of features that are highly ranked across all time
intervals, and the distribution of these features seems to be
roughly equal between labs, procedures, and medications. This
indicates that while labs may be more useful for predicting HACs
immediately after admission and procedural/medication informa-
tion may be more useful for predicting HACs several days after
admission, all three of these feature types are needed to have accu-
rate prediction of HACs.
If we look within each of the categories, there are commonali-
ties between the top two increasing features and top two decreas-
ing features. For example, the infectious complications (Fig. 2) top
two increasing features of single internal mammary-coronary
artery bypass procedure and aortocoronary bypass overlay one
another very closely. The same occurs for red blood cell count
(RBC) maximum lab value and hematocrit (HCT) maximum lab
value. This suggests that bypass-related procedures [22,23,26]
and red blood cell related lab values are predictors for infectious
complications. Similarly, in surgical complications (Fig. 2c) neosy-
nephrine medication and nitroglycerin medication overlay one
another very closely. The same occurs for the features that measure
basophils median lab value and monocytes minimum lab value.
This suggests that vasodilator and vasopressor medications and
white blood cell lab values could be features to help predict surgi-
cal complications [40–46]. In other complications, we also
observed that the feature that measures chlorhexidine medication
is the top median ranked feature, the top mean ranked feature, and
also the number one ranked feature at hour 96. This suggests that
chlorhexidine may be useful in predicting other complications
[47–51].
One of the drawbacks of using information gain ratio to score
the predictive power of features is that this measure tends to inac-
curately assign high values to nominal features with many possible
categories [52]. However, aside from ethnicity of which there are
34 distinct values, the feature space consists of continuous and
binary features aside from a few categorical lab exceptions with
a small amount of nominal values. For example, urine color can
be described as straw, light amber, red, yellow or dark amber. Like-
wise, urine appearance can be described as clear, cloudy, slightly
cloudy, or slightly hazy. Thus, this disadvantage of using informa-
tion gain ratio is mostly mitigated in this study, although it is likely
the reason why ethnicity is ranked so high as a predictor for med-
ical complications (Table 2).Data extraction in this study used several summative statistics
(min/max/median) for continuous features. Such measures do not
encode information about the history of these values over time for
each patient. For example, different patients having measurements
of (1,2,3), (3,2,1), and (1,1,3,3) over time for a given lab test
would end up with identical lab features from our extraction pipe-
line. Future work could go into developing methods for extracting
such temporal information into features for use in the downstream
models, or adopting methods such as those described by Lasko
et al. [53].
4.2. Classification
The generated two-level classifiers were able to achieve rela-
tively good performance, peaking at an AUC of 0.845 for HAC cat-
egory 4 (medical complications). The evolution of classifier AUC
over the time intervals shown in Fig. 3 reveals that the classifier
for medical complications demonstrates a fair amount of nonlin-
earity, whereas the other classifiers perform with a relatively con-
stant AUC across all the tested time intervals. With the exception
of somewhat inferior performance at the shortest time intervals
(mostly due to missing data), the mostly linear performance is
reassuring for the generalizability of the method.
One-to-one case versus control sampling was used to ensure a
relatively high sensitivity in the resulting classifiers. Since some
types of HACs are relatively uncommon within the clinical cohort,
there is an issue of class imbalance. For example, the medical com-
plications subcategory has a class imbalance of nearly 1:50 within
our cohort. Failing to account for the class imbalance would likely
result in classifiers with high specificity but low sensitivity, which
would not be very useful in the clinical setting for detecting HACs.
Bayesian network models were employed for the bottom level
classifiers in order to model the many potential causal relation-
ships between clinical features. There is a significant amount of
dependency between features in our feature space, especially
between the three features that are derived from serial measure-
ments of the same lab tests (min/median/max). In addition, due
to our control down-sampling, our data contained a relatively high
ratio of features to training data, ranging from 25 to 91 events per
feature depending on the time period included. While ‘‘traditional”
classifiers such as logistic regression need as few as 20 events per
feature for reproducibility, it is possible that our classifier may suf-
fer from overfitting, which would limit generalizability [54]. Efforts
216 J.L. Warner et al. / Journal of Biomedical Informatics 59 (2016) 209–217are underway to expand the MIMIC II cohort to upwards of 150,000
patients across multiple institutions, at which point we could pur-
sue re-training to establish generalizability.
The reasoning behind utilizing the two level model is that we
found our machine learning classifiers to generally have good accu-
racy in predicting individual ICD-9-CM codes, but failed to have
good accuracy in predicting overall HAC categories. This two level
model takes advantage of the specificity of ICD-9-CM codes to give
good classifier accuracy but still allows for the classifier to output
HAC categories rather than individual ICD-9-CM predictions.
Empirically, we found that the two-level classifier performed at
levels either comparable to the single-level models or up to 6%
more accurate than the single-level models, depending on the
HAC category or time interval tested.
5. Conclusion
There are many potential applications of our preliminary find-
ings, which have demonstrated internal validity but would also
benefit from validation across other cohorts. The generated classi-
fiers could act as a clinical decision support tool to assist doctors in
the early detection of HACs in clinical settings, although any such
system would have to be prospectively evaluated. The individual
identified features could serve as important markers for clinicians
to keep an eye out for as hospitalization progresses, in order to
catch early signs of HACs. It is clear, based on the fact that all attri-
butes undergo dynamic rank change as a function of time, that the
process of hospitalization for critically ill patients is highly
dynamic and likely progresses through distinct epochs. Future
work will focus on whether these epochs can be determined mech-
anistically, such that the complicated process of critical illness can
be more thoroughly understood.
If early prediction of HACs can be operationalized into preven-
tion of HACs, the potential savings could be enormous. Based on
previous literature of medical claims, we hypothesize that at least
$10 billion of excessive hospital costs due to HACs could be saved
annually (Table A3). In addition to hospital costs, preventing HACs
would translate into the saving of more than 4.6 million days of
excessive hospital stays [55–59]. In conclusion, HACs are a promi-
nent problem in modern day hospitals and provide a significant
drain on the healthcare system. Machine learning classifiers such
as the ones developed in this study could prove to be valuable tools
to assist clinicians in the detection, mitigation, and ultimately pre-
vention of HACs.
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